Patents Assigned to Carnegie Institute of Washington
  • Patent number: 10551393
    Abstract: We describe a high-throughput, phenotypic screening method for one or more modulator(s) of Apolipoprotein B (ApoB) in larval zebrafish. The modulator(s) may be enhancers or inhibitors of ApoB expression. This represents a remarkable opportunity to investigate drug targets in every cell and tissue type of a whole animal without bias, thus maximizing the likelihood of identifying viable pre-therapeutic leads for compounds or biologics in a subject (e.g., human).
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: February 4, 2020
    Assignees: CARNEGIE INSTITUTE OF WASHINGTON, The Johns Hopkins University
    Inventors: James H. Thierer, Steven A. Farber
  • Publication number: 20170015972
    Abstract: The present invention relates generally to an integrated system, apparatus and method that allows for the continuous culturing of microorganisms under high pressure conditions and at a wide range of temperatures. More specifically, the system is configured to be gas tight and operate under aerobic or anaerobic conditions. The system is also configured to permit periodic sampling of the incubated organisms under such conditions with minimal physical/chemical disturbance inside the reactor and minimal impacts of shear forces on the collected biomass.
    Type: Application
    Filed: February 27, 2015
    Publication date: January 19, 2017
    Applicant: Carnegie Institute of Washington
    Inventor: Dionysis Ioannis Foustoukos
  • Publication number: 20090136428
    Abstract: The present invention utilizes fluorescent lipids, particularly quenched phospholipid or cholesterol analogues, to facilitate screening for phenotypes representing perturbations of lipid and/or cholesterol processing in a vertebrate; screening for genetic mutations that lead to disorders of phospholipid and/or cholesterol metabolism; and screening of compounds designed to treat disorders of phospholipid and/or cholesterol metabolism in the vertebrate.
    Type: Application
    Filed: January 30, 2009
    Publication date: May 28, 2009
    Applicants: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, CARNEGIE INSTITUTE OF WASHINGTON
    Inventors: Steven Farber, Michael Pack, Marnie Halpern
  • Patent number: 7488467
    Abstract: The present invention utilizes fluorescent lipids, particularly quenched phospholipid or cholesterol analogues, to facilitate screening for phenotypes representing perturbations of lipid processing; screening for genetic mutations that lead to disorders of phospholipid and/or cholesterol metabolism; and screening of compounds designed to treat disorders of phospholipid and/or cholesterol metabolism.
    Type: Grant
    Filed: January 13, 2003
    Date of Patent: February 10, 2009
    Assignees: Trustees of the University of Pennsylvania, Carnegie Institute of Washington
    Inventors: Steven Farber, Michael Pack, Marnie Halpern
  • Patent number: 7282564
    Abstract: Genes involved in double-stranded RNA interference (RNAi pathway genes) are identified and used to investigate the RNAi pathway. The genes and their products are also useful for modulating RNAi pathway activity.
    Type: Grant
    Filed: August 20, 2003
    Date of Patent: October 16, 2007
    Assignees: University of Massachusetts, Carnegie Institute of Washington
    Inventors: Craig C. Mello, Andrew Fire, Hiroaki Tabara, Alla Grishok
  • Publication number: 20030089117
    Abstract: A method for hydrogen storage includes providing water and hydrogen gas to a containment volume, reducing the temperature of the water and hydrogen gas to form a hydrogen clathrate at a first cryogenic temperature and a first pressure and maintaining the hydrogen clathrate at second cryogenic temperature within a temperature range of up to 250 K to effect hydrogen storage. The low-pressure hydrogen hydrate includes H2O molecules, H2 molecules and a unit cell including polyhedron cages of hydrogen-bonded frameworks of the H2O molecules built around the H2 molecules.
    Type: Application
    Filed: October 24, 2002
    Publication date: May 15, 2003
    Applicant: Carnegie Institute of Washington
    Inventors: Wendy L. Mao, Ho-Kwang Mao
  • Patent number: 6506559
    Abstract: A process is provided of introducing an RNA into a living cell to inhibit gene expression of a target gene in that cell. The process may be practiced ex vivo or in vivo. The RNA has a region with double-stranded structure. Inhibition is sequence-specific in that the nucleotide sequences of the duplex region of the RNA and of a portion of the target gene are identical. The present invention is distinguished from prior art interference in gene expression by antisense or triple-strand methods.
    Type: Grant
    Filed: December 18, 1998
    Date of Patent: January 14, 2003
    Assignee: Carnegie Institute of Washington
    Inventors: Andrew Fire, Stephen Kostas, Mary Montgomery, Lisa Timmons, SiQun Xu, Hiroaki Tabara, Samuel E. Driver, Craig C. Mello